Background Hepatitis A virus (HAV) infection rarely causes fulminanthepatic failure in people with no underlying liver disease.There are limited data on the course of this infection in patientswith chronic hepatitis B and chronic hepatitis C.
Methods We prospectively followed, from June 1990 to July 1997,595 adults with biochemical and histologic evidence of chronichepatitis B (163 patients) or chronic hepatitis C (432 patients)who were seronegative for HAV antibodies. All were tested everyfour months for serum IgM and IgG antibodies to HAV.
Results Twenty-seven patients acquired HAV superinfection, 10of whom had chronic hepatitis B and 17 of whom had chronic hepatitisC. One of the patients with chronic hepatitis B, who also hadcirrhosis, had marked cholestasis (peak serum bilirubin level,28 mg per deciliter [479 µmol per liter]); the other ninehad uncomplicated courses of hepatitis A. Fulminant hepaticfailure developed in seven of the patients with chronic hepatitisC, all but one of whom died. The other 10 patients with chronichepatitis C had uncomplicated courses of hepatitis A.
Conclusions Although most patients with chronic hepatitis Bwho acquired HAV infection had an uncomplicated course, patientswith chronic hepatitis C had a substantial risk of fulminanthepatitis and death associated with HAV superinfection. Ourdata suggest that patients with chronic hepatitis C should bevaccinated against hepatitis A.
Source Information
From the Department of Infectious Diseases, University of Verona, Verona, Italy (S.V., F. Cainelli, E.C.); the Infectious Diseases Unit, A. Pugliese Hospital, Catanzaro, Italy (T.G., T.F.); and the Department of Internal Medicine (C.R., G.G.) and Central Laboratory (F. Casali), San Marino State Hospital, San Marino, Republic of San Marino.
Address reprint requests to Dr. Vento at the Department of Infectious Diseases, University of Verona, via Locchi, 12, 37124 Verona, Italy.
Committee on Infectious Diseases,
(2007). Hepatitis A Vaccine Recommendations. Pediatrics
120: 189-199
[Abstract][Full Text]
Koziel, M. J., Peters, M. G.
(2007). Viral Hepatitis in HIV Infection. NEJM
356: 1445-1454
[Full Text]
Wasley, A., Fiore, A., Bell, B. P.
(2006). Hepatitis A in the Era of Vaccination. Epidemiol Rev
28: 101-111
[Abstract][Full Text]
Crone, C. C., Gabriel, G. M., DiMartini, A.
(2006). An Overview of Psychiatric Issues in Liver Disease for the Consultation-Liaison Psychiatrist. Psychosomatics
47: 188-205
[Abstract][Full Text]
Kusov, Y., Kanda, T., Palmenberg, A., Sgro, J.-Y., Gauss-Muller, V.
(2006). Silencing of Hepatitis A Virus Infection by Small Interfering RNAs.. J. Virol.
80: 5599-5610
[Abstract][Full Text]
Wong, T., Lee, S. S.
(2006). Hepatitis C: a review for primary care physicians. CMAJ
174: 649-659
[Abstract][Full Text]
Nainan, O. V., Xia, G., Vaughan, G., Margolis, H. S.
(2006). Diagnosis of Hepatitis A Virus Infection: a Molecular Approach. Clin. Microbiol. Rev.
19: 63-79
[Abstract][Full Text]
Lugoboni, F., Quaglio, G., Pajusco, B., Foroni, M., Blengio, G., Talamini, G., Mezzelani, P., Des Jarlais, D. C.
(2005). Prevalence of hepatitis A among drug users in north-eastern Italy: Is vaccination necessary in low prevalence areas?. Eur J Public Health
15: 464-466
[Abstract][Full Text]
Lo Re, V III, Kostman, J R
(2005). Management of chronic hepatitis C. Postgrad. Med. J.
81: 376-382
[Abstract][Full Text]
Alter, M. J., Seeff, L. B., Bacon, B. R., Thomas, D. L., Rigsby, M. O., Di Bisceglie, A. M.
(2004). Testing for Hepatitis C Virus Infection Should Be Routine for Persons at Increased Risk for Infection. ANN INTERN MED
141: 715-717
[Abstract][Full Text]
Chou, R., Clark, E. C., Helfand, M.
(2004). Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED
140: 465-479
[Abstract][Full Text]
Sulkowski, M. S., Thomas, D. L.
(2003). Hepatitis C in the HIV-Infected Person. ANN INTERN MED
138: 197-207
[Abstract][Full Text]
Mohsen, A H, Easterbrook, P, Taylor, C B, Norris, S
(2002). Hepatitis C and HIV-1 coinfection. Gut
51: 601-608
[Abstract][Full Text]
Brook, M G
(2002). Sexually acquired hepatitis. Sex. Transm. Infect.
78: 235-240
[Abstract][Full Text]
Fujiwara, K, Yokosuka, O, Ehata, T, Saisho, H, Saotome, N, Suzuki, K, Okita, K, Kiyosawa, K, Omata, M
(2002). Association between severity of type A hepatitis and nucleotide variations in the 5` non-translated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions. Gut
51: 82-88
[Abstract][Full Text]
Herrine, S. K.
(2002). Approach to the Patient with Chronic Hepatitis C Virus Infection. ANN INTERN MED
136: 747-757
[Abstract][Full Text]
Walsh, K, Alexander, G J M
(2001). Update on chronic viral hepatitis. Postgrad. Med. J.
77: 498-505
[Abstract][Full Text]
Lauer, G. M., Walker, B. D.
(2001). Hepatitis C Virus Infection. NEJM
345: 41-52
[Full Text]
Cuthbert, J. A.
(2001). Hepatitis A: Old and New. Clin. Microbiol. Rev.
14: 38-58
[Abstract][Full Text]
Bonacini, M., Puoti, M.
(2000). Hepatitis C in Patients With Human Immunodeficiency Virus Infection: Diagnosis, Natural History, Meta-analysis of Sexual and Vertical Transmission, and Therapeutic Issues. Arch Intern Med
160: 3365-3373
[Abstract][Full Text]
Jacobs, R. J., Margolis, H. S., Coleman, P. J.
(2000). The Cost-effectiveness of Adolescent Hepatitis A Vaccination in States With the Highest Disease Rates. Arch Pediatr Adolesc Med
154: 763-770
[Abstract][Full Text]
Strickland, D. K., Riely, C. A., Patrick, C. C., Jones-Wallace, D., Boyett, J. M., Waters, B., Fleckenstein, J. F., Dean, P. J., Davila, R., Caver, T. E., Hudson, M. M.
(2000). Hepatitis C infection among survivors of childhood cancer. Blood
95: 3065-3070
[Abstract][Full Text]
Kovacs, J. A., Masur, H.
(2000). Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection. NEJM
342: 1416-1429
[Full Text]
Gutfreund, K. S., Bain, V. G.
(2000). Chronic viral hepatitis C: management update. CMAJ
162: 827-833
[Abstract][Full Text]
Kiefer, L. A., Honish, A., Predy, G., Talbot, J. A.
(2000). The seroprevalence of hepatitis A and B in people testing positive for hepatitis C. CMAJ
162: 207-208
[Full Text]
Chu, C M, Yeh, C T, Liaw, Y F
(1999). Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut
45: 613-617
[Abstract][Full Text]
Helbling, B., Renner, E. L., Kammerlander, R.
(1999). Acute Hepatitis A in Patients with Chronic Hepatitis C. ANN INTERN MED
131: 314-314
[Full Text]
Asselah, T., Bernuau, J., Marcellin, P.
(1999). Prevalence of Hepatitis C Virus Infection in Patients Hospitalized for Hepatitis A. ANN INTERN MED
130: 451-451
[Full Text]
Koff, R. S.
(1999). The Case for Routine Childhood Vaccination against Hepatitis A. NEJM
340: 644-645
[Full Text]
Strasser, S. I., McDonald, G. B.
(1999). Hepatitis Viruses and Hematopoietic Cell Transplantation: A Guide to Patient and Donor Management. Blood
93: 1127-1136
[Full Text]
Mele, A., Tosti, M. E., Stroffolini, T., Battegay, M., Naef, M., Bucher, H. C., Leino, T., Pebody, R., Leinikki, P., Martins, E. B., Vento, S., Concia, E., Ghironzi, G.
(1998). Hepatitis Associated with Hepatitis A Superinfection in Patients with Chronic Hepatitis C. NEJM
338: 1771-1773
[Full Text]
Bowman, M. A., Nicklin, D. E.
(1998). New Developments in Family Medicine. JAMA
279: 1437-1438
[Full Text]
(1998). A and C May Spell Trouble. JWatch Infect. Diseases
1998: 3-3
[Full Text]
Wise, M. E., Sorvillo, F.
(2005). Hepatitis A-Related Mortality in California, 1989-2000: Analysis of Multiple Cause-Coded Death Data. Am. J. Public Health
95: 900-905
[Abstract][Full Text]